Published online 10 March 2009
Haematologica, Vol 94, Issue 4, 487-495 doi:10.3324/haematol.13592
Copyright © 2009 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Pinto et al. Supplementary Appendix
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pinto, F. O.
Right arrow Articles by Soulier, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pinto, F. O.
Right arrow Articles by Soulier, J.

Bone Marrow Failure

Diagnosis of Fanconi anemia in patients with bone marrow failure

Fernando O. Pinto1,2, Thierry Leblanc3, Delphine Chamousset1, Gwenaelle Le Roux1, Benoit Brethon3, Bruno Cassinat4, Jérôme Larghero5, Jean-Pierre de Villartay6, Dominique Stoppa-Lyonnet7, André Baruchel3, Gérard Socié2, Eliane Gluckman2, Jean Soulier1

1 Team "Genome Rearrangement and Cancer", APHP Hematology Laboratory, Hôpital Saint-Louis, Paris; INSERM U728 and U944, Hôpital Saint-Louis, Paris; and Université Denis Diderot - Paris 7, Hôpital Saint-Louis, Paris
2 Bone Marrow Transplant Unit, Hôpital Saint-Louis, Paris
3 Pediatric Hematology Department, Hôpital Saint-Louis, Paris
4 AP-HP, Cell Biology Unit, Hôpital Saint-Louis, Paris
5 APHP, Cell Therapy Unit, Hôpital Saint-Louis, Paris
6 INSERM U768, Hôpital Necker, Paris
7 Department of Genetics, Curie Institute, Paris, France

Correspondence: Jean Soulier, MD, PhD, Hematology Laboratory APHP, INSERM U944, Université Denis Diderot, Hôpital Saint-Louis, 1, Av Claude Vellefaux, 75010 Paris, France. E-mail:jean.soulier{at}sls.aphp.fr

Background: Patients with bone marrow failure and undiagnosed underlying Fanconi anemia may experience major toxicity if given standard-dose conditioning regimens for hematopoietic stem cell transplant. Due to clinical variability and/or potential emergence of genetic reversion with hematopoietic somatic mosaicism, a straightforward Fanconi anemia diagnosis can be difficult to make, and diagnostic strategies combining different assays in addition to classical breakage tests in blood may be needed.

Design and Methods: We evaluated Fanconi anemia diagnosis on blood lymphocytes and skin fibroblasts from a cohort of 87 bone marrow failure patients (55 children and 32 adults) with no obvious full clinical picture of Fanconi anemia, by performing a combination of chromosomal breakage tests, FANCD2-monoubiquitination assays, a new flow cytometry-based mitomycin C sensitivity test in fibroblasts, and, when Fanconi anemia was diagnosed, complementation group and mutation analyses. The mitomycin C sensitivity test in fibroblasts was validated on control Fanconi anemia and non-Fanconi anemia samples, including other chromosomal instability disorders.

Results: When this diagnosis strategy was applied to the cohort of bone marrow failure patients, 7 Fanconi anemia patients were found (3 children and 4 adults). Classical chromosomal breakage tests in blood detected 4, but analyses on fibroblasts were necessary to diagnose 3 more patients with hematopoietic somatic mosaicism. Importantly, Fanconi anemia was excluded in all the other patients who were fully evaluated.

Conclusions: In this large cohort of patients with bone marrow failure our results confirmed that when any clinical/biological suspicion of Fanconi anemia remains after chromosome breakage tests in blood, based on physical examination, history or inconclusive results, then further evaluation including fibroblast analysis should be made. For that purpose, the flow-based mitomycin C sensitivity test here described proved to be a reliable alternative method to evaluate Fanconi anemia phenotype in fibroblasts. This global strategy allowed early and accurate confirmation or rejection of Fanconi anemia diagnosis with immediate clinical impact for those who underwent hematopoietic stem cell transplant.

Key words: Fanconi anemia, inherited aplastic anemia, bone marrow failure, fibroblasts, somatic mosaicism.